admin, Author at Rose Capital

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /nas/content/live/rosecapital41/wp-includes/functions.php on line 6114
admin, Author at Rose Capital - Page 9 of 10

Helix TCS Inc. and Rose Capital Acquire 100% of the Preferred Stock of BioTrackTHC

GREENWOOD VILLAGE, CO, Feb. 06, 2018 (GLOBE NEWSWIRE) — Helix TCS, Inc. (OTCQB: HLIX), along with its investment partner Rose Capital, acquired all of the outstanding preferred stock of Bio-Tech Medical Software, Inc. (or BioTrackTHC). This investment represents approximately 18.5% of BioTrackTHC’s outstanding capital stock, on an as-converted to common basis. In addition, Helix CEO Zac Venegas will join BioTrackTHC’s board.

Rose Capital and MM Technology Holdings Partner to Drive Expansion of Mary’s Medicinals Products

DENVER, Jan. 9, 2018 /PRNewswire/ — MM Technology Holdings, LLC, (MM Tech), developer and exclusive distributor of the award-winning transdermal cannabis patch, tinctures and patented gel pens marketed as Mary’s Medicinals cannabis-infused products, today announced that is has partnered with Rose Capital to fuel its rapid growth and market expansion.